1. Home
  2. Advocacy
  3. Latest News and Practice Data
  4. FDA Discusses Registration and Listing Rules for LDTs

FDA Discusses Registration and Listing Rules for LDTs

Dec 10, 2024

On December 3, the FDA led a webinar reviewing compliance for its registration and device listing requirements for laboratory-developed tests (LDTs). These requirements are part of stage 2 of the FDA LDT oversight regulation and take effect May 2026. Stage 1 requirements take effect May 6, 2025.

The CAP had previously urged the FDA to provide more education about the agency’s process for registration and listing how the process would apply to LDTs.

Review the FDA webinar slides and webpage.

Most Recent Content

  1. CIPI Connections: Pathology Meets AI: Translating AI Frameworks into Practice
    Podcasts Podcasts
    Sep 10, 2025
  2. September 9, 2025
    Advocacy Updates Advocacy Updates
    Sep 9, 2025
  3. CAP presidency is "one of the great honors of my career," Dr. Karcher says
    Advocacy Updates Advocacy Updates
    Sep 9, 2025
  4. Letter to Congress: "AI tools make predictions, pathologists make diagnoses"
    Advocacy Updates Advocacy Updates
    Sep 9, 2025
  5. Federal loan policy must encourage, not dissuade, future doctors
    Advocacy Updates Advocacy Updates
    Sep 9, 2025
  6. View All
To Top